J. Ferlay, C. Partensky, and F. Bray, More deaths from pancreatic cancer than breast cancer in the EU by 2017, Acta Oncologica, vol.55, issue.9-10, pp.1158-1160, 2016.

R. L. Siegel, K. D. Miller, and A. Jemal, Cancer statistics, 2018, CA: A Cancer Journal for Clinicians, vol.68, issue.1, pp.7-30, 2018.

A. L. Warshaw and C. F. Castillo, Pancreatic Carcinoma, New England Journal of Medicine, vol.326, issue.7, pp.455-465, 1992.

S. F. Sener, A. Fremgen, H. R. Menck, and D. P. Winchester, Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985?1995, using the National Cancer Database11No competing interests declared., Journal of the American College of Surgeons, vol.189, issue.1, pp.1-7, 1999.

M. Wagner, C. Redaelli, M. Lietz, C. A. Seiler, H. Friess et al., Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma, British Journal of Surgery, vol.91, issue.5, pp.586-594, 2004.

F. Paye, R. Micelli-lupinacci, P. Bachellier, J. Boher, and J. Delpero, Distal pancreatectomy for pancreatic carcinoma in the era of multimodal treatment, British Journal of Surgery, vol.102, issue.3, pp.229-236, 2014.

M. F. Brennan, R. D. Moccia, and D. Klimstra, Management of Adenocarcinoma of the Body and Tail of the Pancreas, Annals of Surgery, vol.223, issue.5, pp.506-512, 1996.

R. E. Schwarz, L. E. Harrison, K. C. Conlon, D. S. Klimstra, and M. F. Brennan, The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma, Journal of the American College of Surgeons, vol.188, issue.5, pp.516-521, 1999.

T. Fujita, T. Nakagohri, N. Gotohda, S. Takahashi, M. Konishi et al., Evaluation of the Prognostic Factors and Significance of Lymph Node Status in Invasive Ductal Carcinoma of the Body or Tail of the Pancreas, Pancreas, vol.39, issue.1, pp.e48-e54, 2010.

Y. Xu, H. Liu, J. Chen, and Q. Zhou, Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009, Thoracic Cancer, vol.1, issue.2, pp.83-86, 2010.

G. Barugola, S. Partelli, S. Crippa, P. Capelli, M. D'onofrio et al., Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy, The American Journal of Surgery, vol.203, issue.2, pp.132-139, 2012.

C. R. Ferrone, G. Marchegiani, T. S. Hong, D. P. Ryan, V. Deshpande et al., Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer, Annals of Surgery, vol.261, pp.12-19, 2015.

J. M. Cloyd, M. H. Katz, J. B. Fleming, R. A. Wolff, G. R. Varadhachary et al., 418 Evolution of Outcomes of Patients With Pancreatic Ductal Adenocarcinoma Undergoing Pancreatoduodenectomy Following Preoperative Therapy, Gastroenterology, vol.150, issue.4, p.S1180, 2016.

V. Moutardier, A reappraisal of preoperative chemoradiation for localized pancreatic head ductal adenocarcinoma in a 5-year single-institution experience, Journal of Gastrointestinal Surgery, vol.8, issue.4, pp.502-510, 2004.

S. Gillen, T. Schuster, C. Meyer-zum-büschenfelde, H. Friess, and J. Kleeff, Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages, PLoS Medicine, vol.7, issue.4, p.e1000267, 2010.

S. Gillen, T. Schuster, C. Meyer-zum-büschenfelde, H. Friess, and J. Kleeff, Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages, PLoS Medicine, vol.7, issue.4, p.e1000267, 2010.

F. Wang, A. J. Gill, M. Neale, V. Puttaswamy, S. Gananadha et al., Adverse Tumor Biology Associated with Mesenterico-Portal Vein Resection Influences Survival in Patients with Pancreatic Ductal Adenocarcinoma, Annals of Surgical Oncology, vol.21, issue.6, pp.1937-1947, 2014.

F. Mierke, S. Hempel, M. Distler, D. E. Aust, H. Saeger et al., Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection, Annals of Surgical Oncology, vol.23, issue.S5, pp.730-736, 2016.

M. Kanda, T. Fujii, T. T. Sahin, A. Kanzaki, S. Nagai et al., Invasion of the Splenic Artery Is a Crucial Prognostic Factor in Carcinoma of the Body and Tail of the Pancreas, Annals of Surgery, vol.251, issue.3, pp.483-487, 2010.

S. Partelli, S. Crippa, G. Barugola, D. Tamburrino, P. Capelli et al., Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection, Annals of Surgical Oncology, vol.18, issue.13, pp.3608-3614, 2011.

K. Shimada, Y. Sakamoto, T. Sano, and T. Kosuge, Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail, Surgery, vol.139, issue.3, pp.288-295, 2006.

T. Mizumoto, H. Toyama, S. Asari, S. Terai, H. Mukubo et al., Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail, Annals of Surgical Oncology, vol.25, issue.3, pp.638-646, 2017.

D. Dindo, N. Demartines, and P. Clavien, Classification of Surgical Complications, Annals of Surgery, vol.240, issue.2, pp.205-213, 2004.

C. Bassi, G. Marchegiani, C. Dervenis, M. Sarr, M. Abu-hilal et al., The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After, Surgery, vol.161, issue.3, pp.584-591, 2017.

M. N. Wente, C. Bassi, C. Dervenis, A. Fingerhut, D. J. Gouma et al., Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS), Surgery, vol.142, issue.5, pp.761-768, 2007.

E. F. Yekebas, L. Wolfram, G. Cataldegirmen, C. R. Habermann, D. Bogoevski et al., Postpancreatectomy Hemorrhage: Diagnosis and Treatment, Annals of Surgery, vol.246, issue.2, pp.269-280, 2007.

D. S. Lu, H. A. Reber, R. M. Krasny, B. M. Kadell, and J. Sayre, Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT., American Journal of Roentgenology, vol.168, issue.6, pp.1439-1443, 1997.

J. D. Brierley, M. K. Gospodarowicz, and C. Wittekind, Urological Tumours, TNM Classification of Malignant Tumours, pp.187-187, 2017.

M. B. Amin, F. L. Greene, S. B. Edge, C. C. Compton, J. E. Gershenwald et al., The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more ?personalized? approach to cancer staging, CA: A Cancer Journal for Clinicians, vol.67, issue.2, pp.93-99, 2017.

R. Fluss, D. Faraggi, and B. Reiser, Estimation of the Youden Index and its Associated Cutoff Point, Biometrical Journal, vol.47, issue.4, pp.458-472, 2005.

J. R. Delpero and A. Sauvanet, Vascular Resection for Pancreatic Cancer: 2019 French Recommendations Based on a Literature Review From 2008 to 6-2019, Frontiers in Oncology, vol.10, p.40, 2020.

L. Schwarz, D. Vernerey, J. Bachet, J. Tuech, F. Portales et al., Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study), BMC Cancer, vol.18, issue.1, p.762, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01857797

J. J. Hyun, J. B. Rose, A. A. Alseidi, T. R. Biehl, S. Helton et al., Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland, Journal of Surgical Oncology, vol.120, pp.262-271, 2019.

M. Bissolati, M. T. Sandri, G. Burtulo, L. Zorzino, G. Balzano et al., Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer, Tumor Biology, vol.36, issue.2, pp.991-996, 2014.

M. Kayahara, H. Nakagawara, H. Kitagawa, and T. Ohta, The Nature of Neural Invasion by Pancreatic Cancer, Pancreas, vol.35, issue.3, pp.218-223, 2007.

C. Neuzillet, A. Sauvanet, and P. Hammel, Prognostic factors for resectable pancreatic adenocarcinoma, Journal of Visceral Surgery, vol.148, issue.4, pp.e232-e243, 2011.

E. Sirri, F. A. Castro, J. Kieschke, L. Jansen, K. Emrich et al., Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States, Pancreas, vol.45, issue.6, pp.908-914, 2016.

M. Collard, T. Marchese, N. Guedj, F. Cauchy, C. Chassaing et al., Is Routine Splenectomy Justified for All Left-Sided Pancreatic Cancers? Histological Reappraisal of Splenic Hilar Lymphadenectomy, Annals of Surgical Oncology, vol.26, issue.4, pp.1071-1078, 2019.

B. H. Kim, K. H. Kim, E. K. Chie, J. Jang, S. W. Kim et al., Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma, Cancer Research and Treatment, vol.47, issue.2, pp.274-281, 2014.

H. Takahashi, H. Ohigashi, K. Gotoh, S. Marubashi, T. Yamada et al., Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer, Annals of Surgery, vol.258, issue.6, pp.1040-1050, 2013.

S. Lof, M. Korrel, J. Van-hilst, A. Alseidi, G. Balzano et al., Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study, Annals of Surgical Oncology, vol.27, issue.6, pp.1986-1996, 2019.

, 2019 Annual Meeting Official Proceedings, Volume XX, Annals of Surgical Oncology, vol.26, issue.S2, pp.225-523, 2019.

, Littérature, Le Rouleau de la guerre, pp.31-33, 1959.

S. Se,

S. Sp,

M. R. Nendaz and A. Perrier, Sensibilité, spécificité, valeur prédictive positive et valeur prédictive négative d?un test diagnostique, Revue des Maladies Respiratoires, vol.21, issue.2, pp.390-393, 2004.

. Vpn, RESUME : Introduction : L'adénocarcinome (ADK) canalaire du corps et de la queue du pancréas s'accompagne fréquemment d'un envahissement des vaisseaux spléniques, mais son impact sur la survie est inconnu

, Graphique 2.1 . Tous les pays ont été touchés d'une manière ou d'une autre par la crise globale de 2008 et 2009, Matériel et méthodes : Tous les patients de cinq centres différents opérés d'un ADK du corps ou de la queue du pancréas et ayant eu une PC entre 2013 et 2019 ont été inclus

. Résultats, 5%) un envahissement unique de la veine splénique et 24 (31.6%) un envahissement combiné de l'artère et de la veine splénique. La capacité du scanner préopératoire à prédire p-SV+ et p-SA+ était élevée (sensibilités respectives : 91, 4% et 82.8%; valeurs prédictives négatives respectives : 89.7% et 88.3%). L'OS et la DFS à 5ans étaient respectivement de 3.9% et 8.3%. Après analyse multivariée, l'envahissement des vaisseaux spléniques (i.e., p-SA+ ou p-SV+, ou à la fois p-SA+ et p-SV+) était le seul facteur impactant la DFS, vol.11, p.0

J. Daubert, Recommandations de la SFC pour la pratique de l?électrophysiologie diagnostique et interventionnelle, Archives des Maladies du Coeur et des Vaisseaux - Pratique, vol.2010, issue.189, p.39, 2010.